PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of canjcardiolThe Canadian Journal of Cardiology HomepageSubscription pageSubmissions Pagewww.pulsus.comThe Canadian Journal of Cardiology
 
Can J Cardiol. 2009 September; 25(9): e334.
PMCID: PMC2780896

Coronary artery-middle cardiac vein fistula after endomyocardial biopsy in a heart transplant patient

S Noble, MD,1 C Frangos, MD,1 and P Roméo, MD2

A 62-year-old man underwent an orthotopic heart transplantation in 2003 for severe valvular cardiomyopathy with end-stage heart failure. The transplantation was successful and the patient remains free of symptoms. The routine post-transplantation follow-up was uneventful. However, the final coronary angiography in 2008 showed a fistula between the posterior descending artery (PDA) originating from the left circumflex coronary artery (LCX) and the middle cardiac vein (MCV) (Figure 1 and Video 1 show the right anterior oblique cranial view; CS indicates coronary sinus). At physical examination, no systolo-diastolic murmur could be heard on the precordium. The fistula was not present in the previous coronary angiography in 2005. A review of the patient’s previous endomyocardial biopsy specimens showed the presence of a small calibre artery (300 μm to 400 μm in diameter), emphasizing the relationship between the biopsies and this fistula. Figure 2 is a Movat colouration showing the internal and external elastic membrane, confirming that the vessel corresponded to an artery.

Acquired coronary artery fistula is a well-known complication of endomyocardial biopsies with an incidence of up to 8%; such fistulas are only seen in 0.2% of the general population (1). Almost all acquired coronary artery fistulas have been described between the right or left coronary arteries and the right ventricle. Very rare cases involving the cardiac veins have been described (2). Most cases are clinically silent and of no hemodynamic significance. Spontaneous regressions have been reported, and in the absence of symptoms, no therapy is usually recommended. However, percutaneous treatment may be offered if symptoms or significant hemodynamic effects develop (3,4).

REFERENCES

1. Sandhu J, Uretsky B, Zerbe T, et al. Coronary artery fistula in the heart transplant patient: A potential complication of endomyocardial biopsy. Circulation. 1989;79:350–6. [PubMed]
2. Veinot J, Ascah K, Davies R, Smith S. Coronary artery-posterior interventricular vein fistula after endomyocardial biopsy in a heart transplant patient. Can J Cardiol. 2002;18:193–4. [PubMed]
3. Gasser R, Koppel H, Luha O, et al. Segmental degradation of left ventricular wall motion after persistent coronary fistula in a posttransplantation patient: A case report and short review of literature. Transplantation. 2000;69:2108–11. [PubMed]
4. Furniss S, Mitchell L, Kitipawong P. Coil embolization of a coronary artery fistula in a post-transplant patient. Eur Heart J. 1995;16:1147. [PubMed]

Articles from The Canadian Journal of Cardiology are provided here courtesy of Pulsus Group